Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 8, 2025
Accession Number:
0001628280-25-016813
Submission Type:
POS AM
CIK:
0001815776
Company Name:
LENZ Therapeutics, Inc.
File Number:
333-278393